Tevogen Bio Holdings Inc. (TVGN) - 8-K Summary
Business Context and Reporting Period
Date of Report: May 10, 2024
Company: Tevogen Bio Holdings Inc.
Event: Entry into a Material Definitive Agreement (Item 1.01).
Counterparty: The Patel Family, LLP (an existing stockholder and affiliate of a 5% beneficial owner).
Key Financial Metrics and Transaction Terms
This filing details a financing arrangement rather than standard operating results. Key terms include:
- Line of Credit Facility: Up to $36.0 million unsecured line of credit.
- Draw Limits: Maximum $1.0 million per calendar month.
- Interest Rate: Fixed rate of the lower of (i) daily SOFR + 2.00% or (ii) 7.00% per annum.
- Interest Payment: Payable in shares of common stock priced at $1.50 per share.
- Maturity: 48 months from the deposit date of each draw.
- Prepayment: Permitted without penalty in cash or stock (stock price: greater of $1.50 or prior day's closing price).
- Commitment Fee: 1,000,000 shares of common stock issued to the Lender within two days of the definitive agreement.
Material Changes and Contingent Equity (PIPE)
The agreement includes a contingent Private Investment in Public Equity (PIPE) option:
- Option Size: Lender may purchase at least $14.0 million of common stock plus an additional amount up to the remaining undrawn facility balance.
- Trigger Condition: Exercisable when the stock price reaches a 10-day trailing volume-weighted average of at least $10.00 per share.
- Pricing: 30% discount to the 10-day trailing volume-weighted average price on the trigger date.
- Exercise Window: Within three trading days of the trigger date.
Ownership Limits and Risks
- Beneficial Ownership Limitation: Issuance is capped to prevent the Lender from owning more than 9.99% of outstanding common stock (unless consented). Pre-funded warrants may be issued instead of stock if this limit is reached.
- Cumulative Cap: Without stockholder consent, total shares issued to the Lender cannot exceed 19.99% of shares outstanding on the agreement date.
- Definitive Agreement Deadline: Must be executed by June 14, 2024.
- Forfeiture Risk: The commitment fee shares are subject to forfeiture if the Lender fails to fund the facility or the PIPE under specified conditions.
Investor Verification Checklist
- Verify the execution of the definitive Transaction Agreement by June 14, 2024.
- Monitor the stock price to determine if the $10.00 threshold for the PIPE option is met.
- Review the impact of the 1,000,000 share commitment fee on immediate dilution.
- Assess the company's ability to service debt via stock issuance at the fixed $1.50 price versus market price.
- Confirm the Lender's status as an affiliate and potential conflicts of interest.
Note: This filing does not provide revenue, profit, cash flow, or margin data. It focuses solely on the terms of the new financing facility.